LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year High at $84.19

Shares of LeMaitre Vascular, Inc. (NASDAQ:LMATGet Free Report) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $84.19 and last traded at $83.87, with a volume of 2060 shares changing hands. The stock had previously closed at $83.62.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on LMAT. StockNews.com cut shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a report on Saturday, June 22nd. Roth Capital raised shares of LeMaitre Vascular to a “strong-buy” rating in a report on Friday, May 31st. Stifel Nicolaus raised shares of LeMaitre Vascular from a “hold” rating to a “buy” rating and increased their price target for the company from $59.00 to $75.00 in a report on Friday, April 26th. Barrington Research increased their price target on shares of LeMaitre Vascular from $69.00 to $79.00 and gave the company an “outperform” rating in a report on Friday, May 3rd. Finally, JMP Securities increased their price target on shares of LeMaitre Vascular from $72.00 to $77.00 and gave the company a “market outperform” rating in a report on Friday, May 3rd. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, LeMaitre Vascular has an average rating of “Moderate Buy” and a consensus target price of $77.57.

View Our Latest Stock Report on LeMaitre Vascular

LeMaitre Vascular Trading Down 0.2 %

The stock’s 50-day simple moving average is $78.55 and its 200-day simple moving average is $67.83. The firm has a market capitalization of $1.87 billion, a P/E ratio of 55.38, a P/E/G ratio of 2.52 and a beta of 0.89.

LeMaitre Vascular (NASDAQ:LMATGet Free Report) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.05. LeMaitre Vascular had a net margin of 16.99% and a return on equity of 11.57%. The firm had revenue of $53.48 million during the quarter, compared to the consensus estimate of $51.50 million. During the same period in the prior year, the firm earned $0.27 EPS. The company’s revenue was up 13.6% compared to the same quarter last year. On average, equities research analysts expect that LeMaitre Vascular, Inc. will post 1.77 EPS for the current year.

LeMaitre Vascular Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 30th. Investors of record on Thursday, May 16th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date of this dividend was Wednesday, May 15th. LeMaitre Vascular’s payout ratio is currently 42.38%.

Insider Activity at LeMaitre Vascular

In related news, Director Bridget A. Ross sold 5,500 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $77.99, for a total transaction of $428,945.00. Following the sale, the director now directly owns 2,278 shares in the company, valued at approximately $177,661.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other LeMaitre Vascular news, Director David B. Roberts sold 5,025 shares of the stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $75.62, for a total value of $379,990.50. Following the sale, the director now directly owns 14,114 shares in the company, valued at approximately $1,067,300.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bridget A. Ross sold 5,500 shares of the stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $77.99, for a total transaction of $428,945.00. Following the completion of the sale, the director now owns 2,278 shares in the company, valued at $177,661.22. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 87,431 shares of company stock worth $6,627,520. 10.79% of the stock is owned by corporate insiders.

Institutional Trading of LeMaitre Vascular

Institutional investors and hedge funds have recently bought and sold shares of the company. Ranger Investment Management L.P. lifted its stake in LeMaitre Vascular by 1.5% in the 4th quarter. Ranger Investment Management L.P. now owns 912,503 shares of the medical instruments supplier’s stock worth $51,794,000 after purchasing an additional 13,681 shares in the last quarter. Congress Asset Management Co. MA lifted its stake in LeMaitre Vascular by 12.0% in the 1st quarter. Congress Asset Management Co. MA now owns 666,083 shares of the medical instruments supplier’s stock worth $44,201,000 after purchasing an additional 71,411 shares in the last quarter. Vanguard Group Inc. lifted its stake in LeMaitre Vascular by 2.3% in the 3rd quarter. Vanguard Group Inc. now owns 1,510,567 shares of the medical instruments supplier’s stock worth $82,296,000 after purchasing an additional 33,500 shares in the last quarter. Mesirow Institutional Investment Management Inc. purchased a new stake in LeMaitre Vascular in the 4th quarter worth approximately $8,837,000. Finally, Congress Wealth Management LLC DE increased its holdings in shares of LeMaitre Vascular by 27.8% in the 1st quarter. Congress Wealth Management LLC DE now owns 98,986 shares of the medical instruments supplier’s stock worth $6,569,000 after buying an additional 21,532 shares during the last quarter. 84.64% of the stock is currently owned by hedge funds and other institutional investors.

LeMaitre Vascular Company Profile

(Get Free Report)

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.

Read More

Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.